INTRODUCTION
D000293:Adolescent; D000328:Adult; D000368:Aged; D000549:Ambenonium Chloride / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use; D009801:Oculomotor Muscles / Q000503:physiopathology; D011247:Pregnancy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012141:Respiratory Tract Infections; D013934:Thymectomy; D013950:Thymus Gland / Q000528:radiation effects
D045930:Anabolic Agents; D009388:Neostigmine; D000549:Ambenonium Chloride; D004809:Ephedrine; D011729:Pyridostigmine Bromide